Skip to main content
logo
3D Medicines Inc. (HKG:1244)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.160
-0.080 (-3.57%)
Jul 31, 2026, 2:03 PM HKT

3D Medicines Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
356.09356.09445.65634.95567.3960.26
Revenue Growth
-20.59%-20.10%-29.81%11.91%841.57%-
Gross Profit
298.97298.97371.74524.01465.2148.83
Operating Income
-206.34-206.34-230.74-497.25-386.17-520.53
Net Income
-177.53-177.53-182.66-524.7-1,024-1,434
Earnings Per Share
-0.72-0.72-0.75-2.30-22.52-36.72
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
437.91437.91840.98996.58942.03824.48
Total Debt
152.78152.78237.62282.43175.73,192
Net Cash (Debt)
285.13285.13603.36714.15766.33-2,367
Net Cash Growth
0.35%-52.74%-15.51%-6.81%--
Net Cash Per Share
1.161.162.463.1316.85-60.61

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-159.26-159.26-210.58-144.41-278.78-377.08
Capital Expenditures
-0.02-0.02-45.36-6.32-53.98-43.87
Free Cash Flow
-159.28-159.28-255.94-150.74-332.76-420.95
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
83.96%83.96%83.41%82.53%81.99%81.03%
Operating Margin
-57.95%-57.95%-51.78%-78.31%-68.06%-863.81%
Pretax Margin
-51.94%-51.94%-44.74%-88.58%-185.42%-2425.86%
Profit Margin
-49.86%-49.86%-40.99%-82.64%-180.54%-2379.84%
FCF Margin
-44.73%-44.73%-57.43%-23.74%-58.65%-698.56%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1.343.301.592.4814.80-